Update on the management of recurrent Cushing's disease

Martin J. Rutkowski, Patrick M. Flanigan, Manish K. Aghi

Research output: Contribution to journalArticle

Abstract

After transsphenoidal surgery, Cushing's disease (CD) shows excellent long-term remission rates, but it may recur and pose a therapeutic challenge. Findings in recent published reports on the treatment of recurrent adrenocorticotropic hormone (ACTH)-secreting tumors suggest that repeat resection, radiation-based therapies such as Gamma Knife surgery and proton-beam radiosurgery, pharmacotherapy, and bilateral adrenalectomy all have important roles in the treatment of recurrent CD. Each of these interventions has inherent risks and benefits that should be presented to the patient during counseling on retreatment options. Radiation-based therapies increasingly appear to have efficacies similar to those of repeat resection in achieving biochemical remission and tumor control. In addition, an expanding retinue of medication-based therapies, several of which are currently being evaluated in clinical trials, has shown some promise as tertiary adjunctive therapies. Lastly, bilateral adrenalectomy may offer durable control of refractory recurrent CD. An increasing number of published studies with long-term patient outcomes highlight the evolving treatment patterns in the management of recurrent CD.

Original languageEnglish (US)
Article numberE16
JournalNeurosurgical focus
Volume38
Issue number2
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Pituitary ACTH Hypersecretion
Adrenalectomy
Radiotherapy
Therapeutics
Retreatment
Radiosurgery
Adrenocorticotropic Hormone
Protons
Counseling
Neoplasms
Clinical Trials
Drug Therapy

Keywords

  • Adenoma
  • Adrenalectomy
  • Adrenocorticotropic hormone
  • Cushing's disease
  • Radiation
  • Radiosurgery
  • Recurrent
  • Surgery

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Update on the management of recurrent Cushing's disease. / Rutkowski, Martin J.; Flanigan, Patrick M.; Aghi, Manish K.

In: Neurosurgical focus, Vol. 38, No. 2, E16, 01.01.2015.

Research output: Contribution to journalArticle

Rutkowski, Martin J. ; Flanigan, Patrick M. ; Aghi, Manish K. / Update on the management of recurrent Cushing's disease. In: Neurosurgical focus. 2015 ; Vol. 38, No. 2.
@article{38b001cca3614bf494aa06ff1ec9b178,
title = "Update on the management of recurrent Cushing's disease",
abstract = "After transsphenoidal surgery, Cushing's disease (CD) shows excellent long-term remission rates, but it may recur and pose a therapeutic challenge. Findings in recent published reports on the treatment of recurrent adrenocorticotropic hormone (ACTH)-secreting tumors suggest that repeat resection, radiation-based therapies such as Gamma Knife surgery and proton-beam radiosurgery, pharmacotherapy, and bilateral adrenalectomy all have important roles in the treatment of recurrent CD. Each of these interventions has inherent risks and benefits that should be presented to the patient during counseling on retreatment options. Radiation-based therapies increasingly appear to have efficacies similar to those of repeat resection in achieving biochemical remission and tumor control. In addition, an expanding retinue of medication-based therapies, several of which are currently being evaluated in clinical trials, has shown some promise as tertiary adjunctive therapies. Lastly, bilateral adrenalectomy may offer durable control of refractory recurrent CD. An increasing number of published studies with long-term patient outcomes highlight the evolving treatment patterns in the management of recurrent CD.",
keywords = "Adenoma, Adrenalectomy, Adrenocorticotropic hormone, Cushing's disease, Radiation, Radiosurgery, Recurrent, Surgery",
author = "Rutkowski, {Martin J.} and Flanigan, {Patrick M.} and Aghi, {Manish K.}",
year = "2015",
month = "1",
day = "1",
doi = "10.3171/2014.11.FOCUS14703",
language = "English (US)",
volume = "38",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "2",

}

TY - JOUR

T1 - Update on the management of recurrent Cushing's disease

AU - Rutkowski, Martin J.

AU - Flanigan, Patrick M.

AU - Aghi, Manish K.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - After transsphenoidal surgery, Cushing's disease (CD) shows excellent long-term remission rates, but it may recur and pose a therapeutic challenge. Findings in recent published reports on the treatment of recurrent adrenocorticotropic hormone (ACTH)-secreting tumors suggest that repeat resection, radiation-based therapies such as Gamma Knife surgery and proton-beam radiosurgery, pharmacotherapy, and bilateral adrenalectomy all have important roles in the treatment of recurrent CD. Each of these interventions has inherent risks and benefits that should be presented to the patient during counseling on retreatment options. Radiation-based therapies increasingly appear to have efficacies similar to those of repeat resection in achieving biochemical remission and tumor control. In addition, an expanding retinue of medication-based therapies, several of which are currently being evaluated in clinical trials, has shown some promise as tertiary adjunctive therapies. Lastly, bilateral adrenalectomy may offer durable control of refractory recurrent CD. An increasing number of published studies with long-term patient outcomes highlight the evolving treatment patterns in the management of recurrent CD.

AB - After transsphenoidal surgery, Cushing's disease (CD) shows excellent long-term remission rates, but it may recur and pose a therapeutic challenge. Findings in recent published reports on the treatment of recurrent adrenocorticotropic hormone (ACTH)-secreting tumors suggest that repeat resection, radiation-based therapies such as Gamma Knife surgery and proton-beam radiosurgery, pharmacotherapy, and bilateral adrenalectomy all have important roles in the treatment of recurrent CD. Each of these interventions has inherent risks and benefits that should be presented to the patient during counseling on retreatment options. Radiation-based therapies increasingly appear to have efficacies similar to those of repeat resection in achieving biochemical remission and tumor control. In addition, an expanding retinue of medication-based therapies, several of which are currently being evaluated in clinical trials, has shown some promise as tertiary adjunctive therapies. Lastly, bilateral adrenalectomy may offer durable control of refractory recurrent CD. An increasing number of published studies with long-term patient outcomes highlight the evolving treatment patterns in the management of recurrent CD.

KW - Adenoma

KW - Adrenalectomy

KW - Adrenocorticotropic hormone

KW - Cushing's disease

KW - Radiation

KW - Radiosurgery

KW - Recurrent

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84942574762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942574762&partnerID=8YFLogxK

U2 - 10.3171/2014.11.FOCUS14703

DO - 10.3171/2014.11.FOCUS14703

M3 - Article

C2 - 25639318

AN - SCOPUS:84942574762

VL - 38

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 2

M1 - E16

ER -